A. Cox

发表

IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function

Jamie B. Spangler, S. Zeger, O. Laeyendecker, 2022, JCI insight.

Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies

Ahnalee M. Brincks, J. M. Crawford, Stefani N. Thomas, 2022, Open forum infectious diseases.

Mitochondrial induced T cell apoptosis and aberrant myeloid metabolic programs define distinct immune cell subsets during acute and recovered SARS-CoV-2 infection

A. Pekosz, J. Powell, A. Hamacher-Brady, 2020, medRxiv.

Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients

J. Blankson, S. Klein, D. Segev, 2022, Transplantation.

Pseudomonas aeruginosa Elicits Sustained IL-1β Upregulation in Alveolar Macrophages from Lung Transplant Recipients

P. Shah, R. Collman, J. Christie, 2022, bioRxiv.

Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries

A. Mammen, M. Roederer, J. Credle, 2022, Nature Biomedical Engineering.

Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology

R. El-Diwany, R. Rothman, K. Shaw-Saliba, 2021, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Discordant antibody and T cell responses to the SARS-CoV-2 Omicron variant in COVID-19 mRNA vaccine recipient

J. Blankson, A. Karaba, Bezawit A. Woldemeskel, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Markers of endothelial cell activation are associated with the severity of pulmonary disease in COVID-19

C. Lowenstein, L. Yanek, Kimberly Smith, 2022, PloS one.

SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection

T. Westlake, J. Blankson, D. Pardoll, 2022, eBioMedicine.

Cross-reactive antibodies facilitate innate sensing of dengue and Zika viruses.

D. Weiner, William H. Aisenberg, A. Durbin, 2022, JCI insight.

Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection

A. Casadevall, S. Cramer, O. Laeyendecker, 2022, JCI insight.

A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response

J. Blankson, S. Klein, D. Segev, 2022, Transplantation.

Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency

G. Shaw, S. Ray, Shuyi Wang, 2022, The Journal of clinical investigation.

The D614G mutation redirects SARS-CoV-2 spike to lysosomes and suppresses deleterious traits of the furin cleavage site insertion mutation

A. Pekosz, Yiwei Ai, Maggie Li, 2022, Science advances.

Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-19.

D. Griffin, Maggie L Bartlett, Nadine Peart Akindele, 2022, Viral immunology.

Title: Mitochondrial induced T cell apoptosis and aberrant myeloid metabolic programs define distinct immune cell subsets during acute and recovered SARS-CoV-2 infection.

M. Horton, Jonathan, R. Rothman, 2020 .

Durable SARS-CoV-2 B cell immunity after mild or severe disease

S. Ray, S. Klein, M. Betenbaugh, 2020, medRxiv.

Evolution of CD8 + T cell responses after acute PARV4 3 infection 4

P. Klenerman, P. Simmonds, P. Bowness, 2013 .

Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology

R. El-Diwany, R. Rothman, Weiqiang Zhou, 2021, medRxiv.

A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients

J. Blankson, S. Klein, D. Segev, 2021, American Journal of Transplantation.

SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge

O. Laeyendecker, J. Blankson, A. Yang, 2022, JCI insight.

IgM autoantibodies recognizing ACE2 are associated with severe COVID-19

Jamie B. Spangler, S. Zeger, O. Laeyendecker, 2020, medRxiv.

Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV.

O. Laeyendecker, J. Blankson, A. Karaba, 2022, AIDS.

A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients

J. Blankson, S. Klein, D. Segev, 2021, American Journal of Transplantation.

Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment

O. Laeyendecker, S. Klein, A. Karaba, 2023, mBio.

Point-of-Care Lung Ultrasound Predicts Severe Disease and Death Due to COVID-19: A Prospective Cohort Study

B. Hansoti, Gigi Y Liu, T. Siddharthan, 2022, medRxiv.

The D614G Mutation Enhances the Lysosomal Trafficking of SARS-CoV-2 Spike

A. Pekosz, S. Gould, N. Atai, 2020, bioRxiv.

Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department

O. Laeyendecker, S. Truelove, J. Blankson, 2022, Journal of clinical microbiology.

Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency department

O. Laeyendecker, S. Truelove, J. Blankson, 2021, medRxiv.

Anti-PF4 antibodies associated with disease severity in COVID-19

Daniel S. Chertow, S. Zeger, D. Follmann, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Persistent SARS-CoV-2–specific immune defects in kidney transplant recipients following third mRNA vaccine dose

S. Klein, D. Segev, D. Warren, 2023, American Journal of Transplantation.

Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients.

S. Klein, S. Dhakal, C. Heaney, 2022, Open forum infectious diseases.

Heterologous versus homologous boosting elicits qualitatively distinct, BA.5–cross-reactive T cells in transplant recipients

J. Blankson, D. Segev, N. Rouphael, 2023, JCI insight.

Persistent SARS-CoV-2–specific immune defects in kidney transplant recipients following third mRNA vaccine dose

S. Klein, D. Segev, D. Warren, 2023, American Journal of Transplantation.

Reduced control of SARS-CoV-2 infection is associated with lower mucosal antibody responses in pregnant women

E. Klein, S. Klein, A. Pekosz, 2023, medRxiv.

Impact of Seasonal Coronavirus Antibodies on SARS-CoV-2 Vaccine Responses in Solid Organ Transplant Recipients

J. Blankson, D. Segev, Y. Eby, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.